308 related articles for article (PubMed ID: 22340704)
1. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.
Suzuki J; Ashizawa M; Okuda S; Wada H; Sakamoto K; Terasako K; Sato M; Kimura SI; Kikuchi M; Nakasone H; Kako S; Yamazaki R; Oshima K; Nishida J; Kanda Y
Transpl Infect Dis; 2012 Aug; 14(4):E7-12. PubMed ID: 22340704
[TBL] [Abstract][Full Text] [Related]
2. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
[TBL] [Abstract][Full Text] [Related]
3. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
[TBL] [Abstract][Full Text] [Related]
4. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
Oshima K; Takahashi T; Mori T; Matsuyama T; Usuki K; Asano-Mori Y; Nakahara F; Okamoto S; Kurokawa M; Kanda Y
Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
[TBL] [Abstract][Full Text] [Related]
6. [Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Teranishi H; Sakiyama M; Nagatoshi Y; Nomura Y; Inagaki J; Yanai F; Okamura J
Rinsho Ketsueki; 2011 May; 52(5):287-92. PubMed ID: 21646775
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
Tauro S; Toh V; Osman H; Mahendra P
Bone Marrow Transplant; 2000 Oct; 26(7):795-6. PubMed ID: 11042663
[TBL] [Abstract][Full Text] [Related]
8. [Varicella-zoster virus meningoencephalitis without skin manifestation in an allogeneic bone marrow transplantation patient successfully treated with aciclovir].
Kobayashi H; Ueno M; Sumi M; Shimizu I; Yotsumoto M; Tanozaki R; Ichikawa N
Rinsho Ketsueki; 2007 Nov; 48(11):1511-3. PubMed ID: 18080512
[TBL] [Abstract][Full Text] [Related]
9. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
Peritz DC; Duncan C; Kurek K; Perez-Atayde AR; Lehmann LE
J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
[TBL] [Abstract][Full Text] [Related]
10. Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
Doki N; Miyawaki S; Tanaka M; Kudo D; Wake A; Oshima K; Fujita H; Uehara T; Hyo R; Mori T; Takahashi S; Okamoto S; Sakamaki H;
Transpl Infect Dis; 2013 Jun; 15(3):314-8. PubMed ID: 23551634
[TBL] [Abstract][Full Text] [Related]
11. [Meningoencephalitis caused by varicella zoster virus].
Weerkamp NJ; Keizer K; Boel CH; de Rijk MC
Ned Tijdschr Geneeskd; 2010; 154():A1575. PubMed ID: 20356422
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia.
Fukuno K; Tomonari A; Takahashi S; Ooi J; Takasugi K; Tsukada N; Konuma T; Iseki T; Moriwaki H; Tojo A; Asano S
Int J Hematol; 2006 Jul; 84(1):79-82. PubMed ID: 16867908
[TBL] [Abstract][Full Text] [Related]
14. Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child.
Spiegel R; Miron D; Lumelsky D; Horovitz Y
J Child Neurol; 2010 Jan; 25(1):87-90. PubMed ID: 19494359
[TBL] [Abstract][Full Text] [Related]
15. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
Cunha BA; Strollo S; Durie N; Ibrahim MS
Heart Lung; 2011; 40(2):164-7. PubMed ID: 21144586
[TBL] [Abstract][Full Text] [Related]
16. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
[TBL] [Abstract][Full Text] [Related]
17. Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children.
Tatebe Y; Ushio S; Esumi S; Sada H; Ochi M; Tamefusa K; Ishida H; Fujiwara K; Kanamitsu K; Washio K; Katsube R; Murakawa K; Zamami Y
Pediatr Blood Cancer; 2022 Dec; 69(12):e29979. PubMed ID: 36151963
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
[TBL] [Abstract][Full Text] [Related]
20. Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.
Truong Q; Veltri L; Kanate AS; Hu Y; Craig M; Hamadani M; Cumpston A
Ann Hematol; 2014 Apr; 93(4):677-82. PubMed ID: 24097085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
